Kang R, Kroemer G, Tang D
Mounjaro's sales dip: How cheap generics are redrawing India's GLP-1 market The arrival of cheaper semaglutide alternatives signals that the Indian obesity drug market has moved from a launch-led boom into something more structurally competitive Eli Lilly's Mounjaro posted its first monthly sales drop in India in Marcha Rs 20-crore decline, from roughly Rs 135 crore in February to Rs 114 crorejust days after a clutch of Indian generics entered the country's booming GLP-1 market
however, its more commonly referred to as a growth hormone (GH) secretagogue, or GHS
At BASS Bariatric Surgery Center in Walnut Creek, we help patients understand all of their options, including medical weight loss programs, gastric sleeve surgery, and gastric bypass surgery
This is consistent with our previous studies using LR3 IGF-1 (Stremming et al., 2021)
female patient with chronic fatigue